ATEM Capital

ATEM is a venture capital firm investing in later-stage life sciences companies, with a focus on biotechnology and pharmaceuticals. It backs innovations addressing unmet clinical need with strong IP protection and invests across France, the United States, and Canada. The firm is relevant for therapeutics and related biotech founders seeking life sciences venture capital; portfolio companies include Amolyt Pharma, Atea Pharmaceuticals, and Syndax Pharmaceuticals.